← MERIT MEDICAL SYSTEMS INC MMSI
Market Price
$90.77
Market Cap
$5.40B
P/E Ratio
42.62
Revenue (FY 2025)
↑11.8% YoY
$1.52B
3-Yr CAGR: 9.6%
Net Income
↑6.8% YoY
$128.49M
Net Margin: 8.5%
Free Cash Flow
↑16.2% YoY
$215.66M
FCF Yield: 3.99%
EPS (Diluted)
↑4.9% YoY
$2.13
Basic: $2.17
Return on Equity
Efficiency
8.1%
ROA: 408.0%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (MMSI)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $603.8M | — | $265.0M | $20.1M | — | $0.45 | — | $53.6M | $20.8M | — |
| FY 2017 | $727.9M | +20.5% | $326.3M | $27.5M | +36.8% | $0.55 | +22.2% | $62.7M | $24.1M | +16.1% |
| FY 2018 | $882.8M | +21.3% | $394.8M | $42.0M | +52.7% | $0.78 | +41.8% | $86.5M | $23.2M | -3.7% |
| FY 2019 | $994.9M | +12.7% | $432.4M | $5.5M | -87.0% | $0.10 | -87.2% | $77.8M | $-0.4M | -101.6% |
| FY 2020 | $963.9M | -3.1% | $401.2M | $-9.8M | -280.6% | $-0.18 | -280.0% | $165.3M | $119.3M | +33,233.9% |
| FY 2021 | $1,074.8M | +11.5% | $485.3M | $48.5M | +592.3% | $0.84 | +566.7% | $147.2M | $119.3M | +0.0% |
| FY 2022 | $1,151.0M | +7.1% | $519.1M | $74.5M | +53.8% | $1.29 | +53.6% | $114.3M | $69.3M | -41.9% |
| FY 2023 | $1,257.4M | +9.2% | $583.9M | $94.4M | +26.7% | $1.62 | +25.6% | $145.2M | $110.9M | +60.1% |
| FY 2024 | $1,356.5M | +7.9% | $643.3M | $120.4M | +27.5% | $2.03 | +25.3% | $220.8M | $185.7M | +67.5% |
| FY 2025 | $1,515.9M | +11.8% | $738.3M | $128.5M | +6.8% | $2.13 | +4.9% | $297.4M | $215.7M | +16.2% |
Valuation
Market Price
$90.77
Market Cap
$5.40B
Enterprise Value
$5.69B
P/E Ratio
42.62
P/B Ratio
3.42
FCF Yield
3.99%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
48.70%
Operating Margin
12.19%
Net Margin
8.48%
Return on Equity (ROE)
8.11%
Return on Assets (ROA)
407.99%
Asset Turnover
48.13x
Revenue 3-Yr CAGR
9.61%
Financial Health & Liquidity
Current Ratio
0.20
Cash Ratio
2.80
Debt / Equity
0.463
Debt / Assets
23.308
Cash & Equivalents
$446.40M
Total Debt
$734.04M
Book Value / Share
$26.56
Cash Flow Efficiency
Operating Cash Flow
$297.37M
Capital Expenditures (CapEx)
$81.72M
Free Cash Flow
$215.66M
OCF / Revenue
19.62%
FCF / Revenue
14.23%
FCF 3-Yr CAGR
46.02%
Per Share Metrics
EPS (Diluted)
$2.13
EPS (Basic)
$2.17
Dividends / Share
N/A
Book Value / Share
$26.56
EPS YoY Growth
4.93%
Balance Sheet (FY 2025)
Total Assets
$31.49M
Total Liabilities
$159.49M
Stockholders' Equity
$1.58B
Current Assets
$31.49M
Current Liabilities
$159.49M